SONOSCAPE(SZ:300633) Sou Hu Cai Jing·2026-02-09 12:41Core Viewpoint - The stock of Kaili Medical (300633) has shown a slight increase in price, with recent trading data indicating mixed capital flows among different investor categories [1][2]. Group 1: Stock Performance and Trading Data - As of February 9, 2026, Kaili Medical's stock closed at 27.39 yuan, up by 0.88%, with a turnover rate of 0.52% and a trading volume of 22,400 lots, amounting to 61.21 million yuan [1]. - On February 9, the net inflow of main funds was 2.21 million yuan, accounting for 3.61% of the total trading volume, while retail investors experienced a net outflow of 4.74 million yuan, representing 7.74% of the total [1]. - Over the past five days, the stock has seen fluctuations in capital flows, with notable net inflows and outflows from different investor categories [1]. Group 2: Company Financial Metrics and Industry Comparison - Kaili Medical's total market capitalization is 11.85 billion yuan, which is above the industry average of 11.08 billion yuan, ranking 30th out of 129 companies in the medical device sector [2]. - The company reported a net profit of 33.51 million yuan, significantly lower than the industry average of 207 million yuan, ranking 77th in the industry [2]. - The company's price-to-earnings ratio stands at 265.26, which is considerably higher than the industry average of 89.2, ranking 91st [2]. - Kaili Medical's gross margin is 60.36%, which exceeds the industry average of 50.16%, ranking 51st [2]. - The company reported a debt ratio of 24.22% and a return on equity (ROE) of 1.07%, which is higher than the industry average of 0.41%, ranking 87th [2]. Group 3: Analyst Ratings - In the last 90 days, five institutions have provided ratings for Kaili Medical, with four giving a "buy" rating and one an "accumulate" rating [3].